An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity

by Ju Youn Beak, PhD, Wei Huang, Joel S. Parker, PhD, Sean T. Hicks, BS, Cam Patterson, MD, Paul C. Simpson, MD, Anqi Ma, PhD, Jian Jin, PhD, Brian C. Jensen, MD
Published 2017-02-01